These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 33966478)

  • 1. Severe Liver Injury Associated With High-Dose Atorvastatin Therapy.
    Saha A; Garg A
    J Investig Med High Impact Case Rep; 2021; 9():23247096211014050. PubMed ID: 33966478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.
    Björnsson E; Jacobsen EI; Kalaitzakis E
    J Hepatol; 2012 Feb; 56(2):374-80. PubMed ID: 21889469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hepatic injury with atorvastatin: an unusual occurrence.
    Vishwakarma P; Nehra R; Kumar A
    Indian J Pharmacol; 2014; 46(3):343-4. PubMed ID: 24987187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute cholestatic hepatitis after atorvastatin reintroduction].
    de Castro ML; Hermo JA; Baz A; de Luaces C; Pérez R; Clofent J
    Gastroenterol Hepatol; 2006 Jan; 29(1):21-4. PubMed ID: 16393626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment associated with atorvastatin and simvastatin.
    King DS; Wilburn AJ; Wofford MR; Harrell TK; Lindley BJ; Jones DW
    Pharmacotherapy; 2003 Dec; 23(12):1663-7. PubMed ID: 14695047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune hepatitis revealed by atorvastatin.
    Pelli N; Setti M; Ceppa P; Toncini C; Indiveri F
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):921-4. PubMed ID: 12867804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of low-density lipoprotein cholestrol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE trial).
    März W; Wollschläger H; Klein G; Neiss A; Wehling M
    Am J Cardiol; 1999 Jul; 84(1):7-13. PubMed ID: 10404843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Statin-related drug-induced liver injury].
    Li XY; Zhong W; Mao YM
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):659-663. PubMed ID: 37400395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
    Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose statins and the IDEAL study.
    Ravnskov U; Rosch PJ; Sutter MC
    JAMA; 2006 Jun; 295(21):2476; author reply 2478-9. PubMed ID: 16757714
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose statins and the IDEAL study.
    Cayley WE
    JAMA; 2006 Jun; 295(21):2476; author reply 2478-9. PubMed ID: 16757713
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose statins and the IDEAL study.
    Ong HT; Cheah JS
    JAMA; 2006 Jun; 295(21):2476-7; author reply 2478-9. PubMed ID: 16757712
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatotoxicity of statins and other lipid-lowering agents.
    Björnsson ES
    Liver Int; 2017 Feb; 37(2):173-178. PubMed ID: 27860156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
    Golomb B; Evans M
    Drug Saf; 2006; 29(12):1191; author reply 1191-2. PubMed ID: 17147465
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe hepatic injury associated with different statins in patients with chronic liver disease: a nationwide population-based cohort study.
    Chang CH; Chang YC; Lee YC; Liu YC; Chuang LM; Lin JW
    J Gastroenterol Hepatol; 2015 Jan; 30(1):155-62. PubMed ID: 25041076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin: a safety and tolerability profile.
    Arca M
    Drugs; 2007; 67 Suppl 1():63-9. PubMed ID: 17910522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of high-dose atorvastatin therapy.
    Waters DD
    Am J Cardiol; 2005 Sep; 96(5A):69F-75F. PubMed ID: 16126026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced liver injury associated with statins.
    Russo MW; Scobey M; Bonkovsky HL
    Semin Liver Dis; 2009 Nov; 29(4):412-22. PubMed ID: 19826975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report.
    Rahier JF; Rahier J; Leclercq I; Geubel AP
    Acta Gastroenterol Belg; 2008; 71(3):318-20. PubMed ID: 19198578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy: the CAPISH study.
    Krasuski RA; Doeppenschmidt D; Henry JS; Smith PB; Adinaro J; Beck R; Thompson CM
    Mayo Clin Proc; 2005 Sep; 80(9):1163-8. PubMed ID: 16178496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.